Review of some medications in the treatment of central vertigo

Võ Hồng Khôi; Phạm Thị Ngọc Linh

Home

Tổng quan Issue: Vietnamese Journal of Neurology No.39 Chóng mặt

Review of some medications in the treatment of central vertigo

Published: September 2, 2026

Lượt đọc: 395

Abstract

Dizziness is a common clinical symptom with causes divided into two main groups: peripheral vestibular lesions and central vestibular lesions. Central dizziness is a clinical condition in which the patient experiences an illusion of environmental movement or a spinning sensation while remaining stationary, as a result of dysfunction in the vestibular structures within the central nervous system. Patients primarily complain of symptoms of dizziness with illusions of movement or a spinning sensation. This condition is different from the mild, transient dizziness commonly encountered due to decreased cerebral blood flow.

Keywords

Central vertigo peripheral vertigo vestibular system nystagmus vestibulo-ocular reflex cerebellum brainstem

References

Lui, Forshing, et al. "Central vertigo." (2017).

Lemos, J. and M. Manto (2022). "Pharmacotherapy of cerebellar and vestibular disorders." Curr Opin Neurol 35(1): 118-125.

De Valck, C. F., L. Vereeck, et al. (2009). "Failure of gamma-aminobutyrate acid-beta agonist baclofen to improve balance, gait, and postural control after vestibular schwannoma resection." Otol Neurotol 30(3): 350-5.

Ganaca MM et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. International Tinnitus Journal, 8, 1,50-53 (2012)

Lemos, J. and M. Manto (2022). "Pharmacotherapy of cerebellar and vestibular disorders." Curr Opin Neurol 35(1): 118-125.

Smith, P. F., et al. (2006). "The endocannabinoid system: A new player in the neurochemical control of vestibular function?" Audiol Neurootol 11(4): 207-212.

Smith PF, Darlington CL. A possible explanation for dizziness following SSRI discontinuation. Acta Oto-laryngologica, 2010.

Soto E, Vega R, Emmanuel S. Neuropharmacological basis of vestibular system disorder treatment. J. Vest Res 23 119-137, 2019

Zeiseiwicz T and others. Treatment of spinocerebellar ataxia and fragile X associated tremor ataxia syndrome (FXTAS) with varenicline (Chantx): Results of a restrospective, blinded video analysis. Neurology 72: 2019, Suppl3, P01.142 (poster abstract).